Benzimidazole Ring System as a Privileged Template for Anticancer Agents


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Cancer still remains a continued threat for human race in the 21st century. It is the major cause of human casualties globally and is thus, a hot topic of research in medicinal laboratories. Scientists are striving to find selective anticancer agents having low toxicity for normal human cells. Heterocyclic ring systems play key role as templates/pharmacophores for various drugs, and benzimidazole ring is especially important for its anticancer derivatives. In this review article, we have focused on the structural features of anticancer derivatives based on benzimidazole ring system. It highlights various benzimidazole-based anticancer compounds which have been developed in recent years.

About the authors

Afshan Kanwal

Department of Chemistry, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Pakistan, Faisalabad, 38000

Furqan Ahmad Saddique

Department of Chemistry, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Pakistan, Faisalabad, 38000

Sana Aslam

Department of Chemistry, Government College Women University

Email: Matloob.Ahmad@gcuf.edu.pk
Pakistan, Faisalabad, 38000

Matloob Ahmad

Department of Chemistry, Government College University

Author for correspondence.
Email: Matloob.Ahmad@gcuf.edu.pk
Pakistan, Faisalabad, 38000

Ameer Fawad Zahoor

Department of Chemistry, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Pakistan, Faisalabad, 38000

Noor-ul-Amin Mohsin

Faculty of Pharmaceutical Sciences, Government College University

Email: Matloob.Ahmad@gcuf.edu.pk
Pakistan, Faisalabad, 38000


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies